))
Krystal Biotech, Patient Impact Award
Manage episode 408981490 series 3347911
Content provided by Life Sciences Pennsylvania. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Life Sciences Pennsylvania or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
A new episode of Being a Life Sciences Leader, honoring the 2023 Patient Impact Award recipient, is now available. In this episode, Krish Krishnan, Chairman & CEO, and Suma Krishnan, President of Research & Development, discuss Krystal Biotech's VYJUVEK - the first ever FDA approved redosable gene therapy.
44 episodes
Share
